This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. Two goals of the book are to make the material accessible to readers with minimal background in research and to be straightforward enough for self-taught purposes. By bringing the topic from the early discovery phase to clinical trials and medical practice, the book provides an indispensable overview of an otherwise confusing and fragmented set of topics. The author’s experience as a respected scientist, teacher of statistics, and one who has worked in the clinical trials arena makes him well suited to write such a treatise.
"synopsis" may belong to another edition of this title.
Praise for New Drug Development
"I highly recommend this text as a comprehensive and very readable presentation of the process and nuances of new drug development. It is a concise and practical book that is well suited for several groups [including] individuals working in pharmaceutical drug development, healthcare providers, and students aspiring to work in either profession."
—Anita Flick, MD, Health Professions Advising, North Carolina State University
"Dr. Turner's book provides a panoramic overview of the complex process of new drug development, integrating discussions of drug discovery, nonclinical research, pre-approval clinical trials, and post-marketing surveillance. Students and professionals entering the worlds of pharmaceutical clinical research and medical practice will benefit greatly from this book, which is now required reading in our company."
—Anton-Lewis Usala, MD, President and CEO, Clinical Trials Management Group, Inc.
An indispensable and modern overview of the design concepts and statistical practices involved in therapeutic drug development
From the initial stages of identifying a potential drug candidate to receiving FDA approval, New Drug Development focuses on the collection, analysis, and interpretation of numerical representations of information throughout the drug development process. This timely text provides a self-contained overview of the new drug development process, while also emphasizing the importance of ethical, biological, social, and political considerations.
Using a relatively pragmatic approach, the author clearly illustrates how the discipline of statistics makes a central contribution to the complex process of new drug development, and these statistical issues are presented conceptually rather than computationally. This book features:
A realistic, scientific, and progressive organization from pre-clinical studies to clinical research that is educationally powerful
The discovery and development of new drugs using the latest advances in various fields, including molecular biology, computational chemistry and biology, computer-aided molecular design, proteomics, and bioinformatics
The design, methodology, and analysis essential for the development of drugs that succeed in safely treating diseases and conditions of clinical concern
New Drug Development is an essential guide for entry-level professionals in the pharmaceutical, biotechnology, and contract research organization (CRO) industries as well as seasoned clinical research professionals who wish to refresh their knowledge in areas outside their immediate fields of expertise.About the Author:
J. Rick Turner, PhD, is Chairman of the Department of Clinical Research at Campbell University School of Pharmacy in Morrisville, North Carolina. A Fellow of the Society of Behavioral Medicine, his areas of interest include cardiovascular behavioral medicine, drug development, and clinical submissions. Dr. Turner has authored several books as well as more than fifty articles in professional journals, and he received a Commit to Product Development Award from GlaxoSmithKline in 2005.
"About this title" may belong to another edition of this title.
Book Description Book Condition: Brand New. Brand New Original US Edition, Perfect Condition. Printed in English. Excellent Quality, Service and customer satisfaction guaranteed!. Bookseller Inventory # AIND-110808
Book Description Book Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery. Bookseller Inventory # AUSBNEW-110808